Xcel Energy Inc. · XEL · FY2025 Q4 · Calendar Q1 2026
Xcel maintains 2026 outlook as data-center demand drives investment
The call supports a constructive operating thesis: management described resilient data-center demand and continued infrastructure investment as growth drivers, while maintaining 2026 EPS guidance. The thesis still depends on regulatory outcomes and disciplined execution of a large capital program.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about XEL FY2025 Q4
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Management highlighted progress from data-center demand, including a reported increase in contracted capacity toward 2027, and described new strategic partnerships with NextEra Energy and GE Vernova. The investment agenda remained central, while rate cases and wildfire-related exposure continued to require monitoring.
Guidance delta
Management maintained 2026 EPS guidance of $4.04-$4.16.
Key takeaways
- Management maintained 2026 EPS guidance while emphasizing execution of its multi-year investment plan.
- Data-center demand and contracted capacity were presented as important long-term growth drivers.
- Wildfire exposure, rate cases, capital execution, and financing costs remain key risks to monitor.
Management priorities
- Execute the 2026-2030 capital plan across renewables, natural gas, storage, and transmission.
- Expand data-center contracts and large-load tariff frameworks.
- Advance partnerships, rate cases, and wildfire-mitigation investments.
Follow XEL with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Sep 18, 2026 |
| Truist Securities | Buy | Buy | Maintain | Aug 13, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 22, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 16, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 9, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jun 23, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | May 4, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Apr 21, 2026 |
| UBS | Buy | Buy | Maintain | Apr 20, 2026 |
| Citigroup | Buy | Buy | Maintain | Nov 3, 2025 |
| Jefferies | Buy | Buy | Maintain | Oct 16, 2025 |
| B of A Securities | Buy | Buy | Maintain | Sep 25, 2025 |
| Wells Fargo | Overweight | Overweight | Maintain | Apr 28, 2025 |
| Argus Research | Buy | Hold | Upgrade | Aug 26, 2024 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Mar 11, 2024 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jan 30, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Jun 8, 2023 |
| Credit Suisse | Neutral | Outperform | Downgrade | Nov 21, 2022 |
| CFRA | Sell | Sell | Maintain | Jan 30, 2020 |
| Bank of America | Underperform | Neutral | Downgrade | Sep 30, 2019 |
| Argus | Buy | Buy | Maintain | Nov 5, 2018 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Sep 26, 2016 |
| Baird | Neutral | Outperform | Downgrade | Mar 2, 2016 |
| Macquarie | Neutral | Outperform | Downgrade | Jan 29, 2016 |
| Deutsche Bank | Hold | Hold | Maintain | Dec 17, 2014 |
| DA Davidson | Neutral | Neutral | Maintain | Aug 2, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $70.69. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Scotiabank | Ian Rapp | $77 | $69.39 | +8.9% | Sep 29, 2026 |
| Morgan Stanley | Analyst unavailable | $83 | $72.53 | +17.4% | Sep 18, 2026 |
| Truist Financial | Analyst unavailable | $88 | $79.14 | +24.5% | Aug 13, 2026 |
| BTIG | Analyst unavailable | $99 | $78.69 | +40.0% | Jul 31, 2026 |
| Mizuho Securities | Analyst unavailable | $92 | $78.23 | +30.1% | Jul 31, 2026 |
| BMO Capital | Analyst unavailable | $92 | $79.83 | +30.1% | Jul 22, 2026 |
| Barclays | Nicholas Campanella | $90 | $79.17 | +27.3% | Jul 9, 2026 |
| Jefferies | Analyst unavailable | $101 | $80.37 | +42.9% | Jul 7, 2026 |
| BTIG | Analyst unavailable | $98 | $81.75 | +38.6% | Jun 26, 2026 |
| Morgan Stanley | Analyst unavailable | $89 | $80.86 | +25.9% | Jun 24, 2026 |
| New Street | Analyst unavailable | $91 | $78.81 | +28.7% | Jun 23, 2026 |
| Morgan Stanley | Analyst unavailable | $87 | $79.93 | +23.1% | May 21, 2026 |
| Truist Financial | Analyst unavailable | $92 | $77.92 | +30.1% | May 18, 2026 |
| Barclays | Analyst unavailable | $87 | $80.6 | +23.1% | May 12, 2026 |
| Evercore ISI | Analyst unavailable | $96 | $82.26 | +35.8% | May 4, 2026 |
| Morgan Stanley | Analyst unavailable | $92 | $79.38 | +30.1% | Apr 21, 2026 |
| KeyBanc | Analyst unavailable | $90 | $80.32 | +27.3% | Apr 21, 2026 |
| Truist Financial | Richard Sunderland | $95 | $80.32 | +34.4% | Apr 20, 2026 |
| UBS | William Appicelli | $91 | $81.72 | +28.7% | Apr 20, 2026 |
| Barclays | Nicholas Campanella | $91 | $81.08 | +28.7% | Apr 20, 2026 |
| Argus Research | Gary Hovis | $86 | $81 | +21.7% | Mar 12, 2026 |
| Morgan Stanley | Analyst unavailable | $91 | $81.25 | +28.7% | Feb 20, 2026 |
| UBS | William Appicelli | $89 | $78.98 | +25.9% | Feb 13, 2026 |
| BMO Capital | Analyst unavailable | $90 | $75.57 | +27.3% | Feb 6, 2026 |
| BTIG | Analyst unavailable | $94 | $75.97 | +33.0% | Jan 30, 2026 |
| RBC Capital | Stephen D'Ambrisi | $95 | $74.44 | +34.4% | Jan 23, 2026 |
| Barclays | Analyst unavailable | $82 | $76.2 | +16.0% | Jan 15, 2026 |
| Mizuho Securities | Anthony Crowdell | $86 | $73.72 | +21.7% | Jan 9, 2026 |
| UBS | William Appicelli | $81 | $73.73 | +14.6% | Dec 17, 2025 |
| KeyBanc | Analyst unavailable | $84 | $74.77 | +18.8% | Dec 12, 2025 |
| Morgan Stanley | David Arcaro | $84 | $79.66 | +18.8% | Nov 20, 2025 |
| UBS | Analyst unavailable | $85 | $81.59 | +20.2% | Nov 5, 2025 |
| UBS | William Appicelli | $86 | $81.18 | +21.7% | Oct 31, 2025 |
| Mizuho Securities | Anthony Crowdell | $87 | $80.96 | +23.1% | Oct 27, 2025 |
| Morgan Stanley | Analyst unavailable | $86 | $80.88 | +21.7% | Oct 22, 2025 |
| BTIG | Alex Kania | $96 | $80.64 | +35.8% | Oct 21, 2025 |
| Jefferies | Analyst unavailable | $92 | $81.6 | +30.1% | Oct 16, 2025 |
| BMO Capital | James Thalacker | $87 | $80.98 | +23.1% | Oct 15, 2025 |
| KeyBanc | Analyst unavailable | $85 | $80.85 | +20.2% | Oct 15, 2025 |
| UBS | William Appicelli | $84 | $81.26 | +18.8% | Oct 10, 2025 |
| Evercore ISI | Analyst unavailable | $92 | $81 | +30.1% | Oct 6, 2025 |
| Barclays | Analyst unavailable | $81 | $79.28 | +14.6% | Sep 29, 2025 |
| UBS | William Appicelli | $82 | $77.25 | +16.0% | Sep 25, 2025 |
| BMO Capital | Analyst unavailable | $84 | $77.25 | +18.8% | Sep 25, 2025 |
| Mizuho Securities | Analyst unavailable | $83 | $77.25 | +17.4% | Sep 25, 2025 |
| Mizuho Securities | Anthony Crowdell | $80 | $73.04 | +13.2% | Sep 24, 2025 |
| Morgan Stanley | David Arcaro | $78 | $69.21 | +10.3% | May 22, 2025 |
| Wells Fargo | Neil Kalton | $78 | $69 | +10.3% | Apr 25, 2025 |
| Morgan Stanley | David Arcaro | $79 | $71.55 | +11.8% | Apr 23, 2025 |
| Barclays | Nicholas Campanella | $73 | $71.39 | +3.3% | Apr 22, 2025 |
| Barclays | Nicholas Campanella | $67 | $64.07 | -5.2% | Oct 21, 2024 |
| Mizuho Securities | Paul Fremont | $70 | $64.17 | -1.0% | Sep 25, 2024 |
| Jefferies | Paul Zimbardo | $70 | $64.06 | -1.0% | Sep 19, 2024 |
| Argus Research | Marie Ferguson | $68 | $60.12 | -3.8% | Aug 26, 2024 |
| Mizuho Securities | Paul Fremont | $64 | $52.43 | -9.5% | Jul 2, 2024 |
| Barclays | Nicholas Campanella | $57 | $54.48 | -19.4% | Apr 30, 2024 |
| BMO Capital | James Thalacker | $65 | $54.79 | -8.0% | Apr 29, 2024 |
| KeyBanc | Sophie Karp | $65 | $53.76 | -8.0% | Apr 19, 2024 |
| Barclays | Nicholas Campanella | $54 | $52.91 | -23.6% | Mar 11, 2024 |
| Wolfe Research | Steve Fleishman | $58 | $52.91 | -18.0% | Mar 11, 2024 |
| J.P. Morgan | Jeremy Tonet | $70 | $61.43 | -1.0% | Dec 4, 2023 |
| Morgan Stanley | Analyst unavailable | $63 | $67.14 | -10.9% | Nov 11, 2022 |
| Evercore ISI | Durgesh Chopra | $79 | $74.78 | +11.8% | May 16, 2022 |
| Wells Fargo | Analyst unavailable | $79 | $74.88 | +11.8% | Apr 29, 2022 |
| Credit Suisse | Nicholas Campanella | $80 | $74.88 | +13.2% | Apr 28, 2022 |
| Morgan Stanley | Analyst unavailable | $75 | $75.36 | +6.1% | Apr 20, 2022 |
| Goldman Sachs | Insoo Kim | $76 | $62.14 | +7.5% | Oct 12, 2021 |
Track every rating change on XEL the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationXcel Energy Inc., through its various operating units, functions as a multifaceted energy company involved in the complete cycle of electricity – from its production and procurement to its transmission, delivery, and eventual sale. Its business is organized into three main divisions: Regulated Electric Utility, Regulated Natural Gas Utility, and a final "All Other" segment. The company employs a diverse range of energy sources for electricity generation, including traditional options like coal, nuclear power, natural gas, and oil, as well as a strong focus on renewables such as hydroelectric, solar, biomass, wood/refuse, and wind. In addition to its electric services, Xcel Energy is active in the natural gas sector, managing the acquisition, pipeline transport, distribution, and retail sales of natural gas.…
Historical context
All XEL earningsLatest beats and misses
Who reports nextBeat on EPS
- COSTFY2026 Q4 · September 24, 2026+3.2% EPS+2.9% move
- SNXFY2026 Q3 · September 24, 2026+20.9% EPS-9.9% move
- DRIFY2027 Q1 · September 24, 20260.0% EPS-3.0% move
- CTASFY2027 Q1 · September 23, 2026+3.0% EPS-3.4% move
- PAYXFY2027 Q1 · September 23, 2026+1.5% EPS-8.8% move
- GISFY2027 Q1 · September 23, 2026+4.6% EPS+1.0% move
Get the XEL recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:36:15.940040+00:00
- Polygon adjusted daily market bars · 2026-09-30T04:26:05.004239+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-30T04:26:05.000167+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-30. For educational purposes only; not investment advice.